-
Embryo-fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies.
Giambona A, Damiani G, Leto F, Jakil C, Renda D, Cigna V, Schillaci G, Picciotto F, Nicolaides KH, Passarello C, Makrydimas G, Maggio A.
Prenat Diagn 2016;36:375-81. pdf -
Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy.
Grossman KB, Arya R, Peixoto AB, Akolekar R, Staboulidou I, Nicolaides KH.
Am J Obstet Gynecol 2016;215:466.e1-8. pdf -
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:21-5. -
Feasibility of DNA diagnosis of haemoglobinopathies on coelocentesis.
Giambona A, Makrydimas G, Leto F, Damiani G, Jakil MC, Picciotto F, Renda D, Fiorino R, Renda MC, Schillaci G, Gueli-Alletti D, Nicolaides KH, Maggio A.
Br J Haematol 2011;153:268-72. -
Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:819-23. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation.
Gerovassili A, Nicolaides KH, Thein SL, Rees DC.
Br J Haematol 2006;135:738-41. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS alpha2gammabetaS) in sickle cell disease.
Ofori-Acquah SF, Green BN, Davies SC, Nicolaides KH, Serjeant GR, Layton DM.
Anal Biochem 2001;298:76-82. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Audit of prenatal diagnosis for hemoglobin disorders in the United Kingdom The first twenty years.
Modell B, Petrou M, Layton M, Varnavides L, Moisely C, Ward RH, Rodeck C, Nicolaides K, Fitches A, Old J.
Ann N Y Acad Sci 1998;850:420-2. -
Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: The first 20 years.
Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward R H, Rodeck C, Nicolaides KH, Gibbons S, Fitches A, Old J.
BMJ 1997;315:779-84.